Biodexa Pharmaceuticals PlcBDRXEarnings & Financial Report
Nasdaq
Biodexa Pharmaceuticals Plc is a clinical-stage biopharmaceutical company focused on developing innovative therapies for central nervous system disorders, including epilepsy and rare neurodegenerative conditions. It operates primarily across European and North American markets, advancing multiple pipeline candidates through clinical trials to address unmet patient needs.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| MERCER STREET GLOBAL OPPORTUNITY FUND, LLC | 9.99% | 109.4M | — | 2024-01-08 |
| Brio | 9.00% | 167.7K | ▼ -0.83pp | 2024-11-20 |
| Ionic Ventures, LLC | 4.90% | 135.5K | — | 2024-02-14 |
| Armistice Capital, LLC | 0.94% | 25.0K | — | 2024-02-14 |
| Iroquois Capital Management L.L.C. | 0.26% | 43.9K | ▼ -7.04pp | 2024-11-14 |
| Cavalry Fund I LP | 0.00% | 59.6K | ▼ -9.90pp | 2024-11-07 |
| CVI Investments, Inc. | 0.00% | — | — | 2024-02-14 |
| Bigger Capital Fund, LP | — | 34.1M | — | 2024-11-12 |